About this trial
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)
Eligibility criteria
Qualifiers
Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
Willingness to sign an Informed Consent Document or verbally agree to participation
Disqualifiers
There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included
Trial design
Treatments tested in this trial
- SRS/SBRT
Treatment groups
Sponsors and collaborators
The Radiosurgery Society
Lead sponsor
VisionTree
Collaborator